Search Results - "Daheng He"
-
1
p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer
Published in Oncogene (07-05-2020)“…Blockade of programmed death-ligand 1 (PD-L1) by therapeutic antibodies has shown to be a promising strategy in cancer therapy, yet clinical response in many…”
Get full text
Journal Article -
2
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression
Published in Nature communications (26-06-2020)“…Dysregulation of polyamine metabolism has been linked to the development of colorectal cancer (CRC), but the underlying mechanism is incompletely…”
Get full text
Journal Article -
3
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
Published in Nature communications (29-10-2020)“…Metastatic melanoma remains an incurable disease for many patients due to the limited success of targeted and immunotherapies. BRAF and MEK inhibitors reduce…”
Get full text
Journal Article -
4
Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
Published in Frontiers in oncology (31-07-2020)“…Fatty acid synthase, a key enzyme of lipogenesis, is an attractive therapeutic target in cancer. The novel fatty acid synthase inhibitor, TVB-3664, shows…”
Get full text
Journal Article -
5
Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD
Published in PLoS genetics (17-06-2024)“…PLK1 (Polo-like kinase 1) plays a critical role in the progression of lung adenocarcinoma (LUAD). Recent studies have unveiled that targeting PLK1 improves the…”
Get full text
Journal Article -
6
Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues
Published in eLife (18-08-2021)“…Although Pembrolizumab-based immunotherapy has significantly improved lung cancer patient survival, many patients show variable efficacy and resistance…”
Get full text
Journal Article -
7
Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression
Published in Cancers (05-01-2022)“…Altered fatty acid metabolism continues to be an attractive target for therapeutic intervention in cancer. We previously found that colorectal cancer (CRC)…”
Get full text
Journal Article -
8
Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth
Published in International journal of molecular sciences (01-05-2024)“…Fatty acid synthesis has been extensively investigated as a therapeutic target in cancers, including colorectal cancer (CRC). Fatty acid synthase (FASN), a key…”
Get full text
Journal Article -
9
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling
Published in PLoS genetics (21-11-2023)“…Metastasis of lung adenocarcinoma (LUAD) is a major cause of death in patients. Aryl hydrocarbon receptor (AHR), an important transcription factor, is involved…”
Get full text
Journal Article -
10
Latexin regulates sex dimorphism in hematopoiesis via gender-specific differential expression of microRNA 98-3p and thrombospondin 1
Published in Cell reports (Cambridge) (28-03-2023)“…Hematopoietic stem cells (HSCs) have the ability to self-renew and differentiate to all blood cell types. HSCs and their differentiated progeny show sex/gender…”
Get full text
Journal Article -
11
Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer
Published in International journal of molecular sciences (10-06-2022)“…Altered lipid metabolism is a potential target for therapeutic intervention in cancer. Overexpression of Fatty Acid Synthase (FASN) correlates with poor…”
Get full text
Journal Article -
12
The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer
Published in International journal of molecular sciences (08-06-2022)“…Aberrant levels of reactive oxygen species (ROS) are potential mechanisms that contribute to both cancer therapy efficacy and the side effects of cancer…”
Get full text
Journal Article -
13
Upregulation of Fatty Acid Synthase Increases Activity of β-Catenin and Expression of NOTUM to Enhance Stem-like Properties of Colorectal Cancer Cells
Published in Cells (Basel, Switzerland) (08-10-2024)“…Dysregulated fatty acid metabolism is an attractive therapeutic target for colorectal cancer (CRC). We previously reported that fatty acid synthase (FASN), a…”
Get full text
Journal Article -
14
Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity
Published in Frontiers in oncology (29-03-2022)“…Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains…”
Get full text
Journal Article -
15
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Published in Advanced science (01-07-2021)“…Because there is no effective treatment for late‐stage prostate cancer (PCa) at this moment, identifying novel targets for therapy of advanced PCa is urgently…”
Get full text
Journal Article -
16
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Published in Advanced science (01-07-2022)Get full text
Journal Article -
17
Nitrogen-rich carbon-supported ultrafine MoC nanoparticles for the hydrotreatment of oleic acid into diesel-like hydrocarbons
Published in Chemical engineering journal (Lausanne, Switzerland : 1996) (15-02-2020)“…[Display omitted] •Ultrafine molybdenum carbide supported on nitrogen-rich carbon (MoC/CN) are synthesized with a facile one-step route.•Molybdenum carbide…”
Get full text
Journal Article -
18
Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer
Published in The Prostate (01-11-2023)“…Androgen signaling inhibitors (ASI) have been approved for treatment of metastatic castration-resistant prostate cancer (mCRPC). However, the limited success…”
Get full text
Journal Article -
19
Sex Dimorphism in the Bone Marrow Niche Contributes to Gender Difference in Mouse Hematopoiesis
Published in Blood (15-11-2022)Get full text
Journal Article -
20
The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness
Published in Proceedings of the National Academy of Sciences - PNAS (16-05-2023)“…Aberrant accumulation of succinate has been detected in many cancers. However, the cellular function and regulation of succinate in cancer progression is not…”
Get full text
Journal Article